Press Releases on October 13, 2020 - EIN Presswire - Press Release Distribution Service

Published on October 13, 2020 - 10:18 GMT

Human medicines European public assessment report (EPAR): Oxlumo, Lumasiran, Hyperoxaluria, Primary, Date of authorisation: 19/11/...

Patients with primary hyperoxaluria type 1 have high levels of glyoxylate which is converted into oxalate. High levels of oxalate can cause stones in the kidney as well as injury to certain organs. The active substance in Oxlumo, lumasiran, blocks the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2020 - 10:16 GMT

JHM Group Signs MoU with Napollo Software Design Worth $2.4mn to implement new technologies in UAE

Key objective of strategic agreement is to accelerate adoption of best practices and digitally transform JHM Group operations across the Region DUBAI, UNITED ARAB EMIRATES, October 13, 2020 /⁨EINPresswire.com⁩/ -- JHM Group of Companies has announced the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 13, 2020 - 10:12 GMT

Revenue Cycle Management Market Share Forecast to Witness Considerable Growth from 2020 to 2027, Latest Report

Recent innovations and growth in adoption of advanced healthcare systems have further fueled the RCM market growth. PORTLAND, OREGON, UNITED STATES, October 13, 2020 /⁨EINPresswire.com⁩/ -- The Objective of the Revenue Cycle Management Market report is to …

Distribution channels: IT Industry, Technology ...

Published on October 13, 2020 - 10:12 GMT

Commencement of Production from Sara and Suri Leases and Settlement of Debentures

CALGARY, Alberta, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Jura Energy Corporation ("Jura" or the "Company") announced today that commercial production has commenced from the Sara and Suri leases under a third party sale arrangement. The …

Distribution channels: Media, Advertising & PR

Published on October 13, 2020 - 10:08 GMT

Human medicines European public assessment report (EPAR): Libmeldy, Autologous CD34+ cells encoding ARSA gene, Leukodystrophy, ...

Libmeldy is a medicine used to treat children with metachromatic leukodystrophy (MLD). MLD is a rare inherited disorder in which there is a change (mutation) in a gene needed to make an enzyme called arylsulfatase A (ARSA), which breaks down substances …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2020 - 10:08 GMT

Digital Health Market to Experience a Massive Growth Owing to Increased Awareness Regarding Healthcare - Exclusive Report [320 ...

New York, USA, Oct. 13, 2020 (GLOBE NEWSWIRE) -- The latest research report on the global digital health devices market by Research Dive reflects the influence of COVID-19 pandemic on the present and expected growth of the global market. This report is …

Distribution channels:

Published on October 13, 2020 - 10:01 GMT

Human medicines European public assessment report (EPAR): Leqvio, inclisiran, Hypercholesterolemia;Dyslipidemias, Date of ...

Leqvio is a medicine used to reduce cholesterol in the blood. It is used in adults with primary hypercholesterolaemia or mixed dyslipidaemia (conditions that cause high levels of fats, including cholesterol, in the blood). It should be used with a low-fat …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on October 13, 2020 - 10:01 GMT

Human medicines European public assessment report (EPAR): Leqvio, inclisiran, Hypercholesterolemia;Dyslipidemias, Date of ...

Leqvio is a medicine used to reduce cholesterol in the blood. It is used in adults with primary hypercholesterolaemia or mixed dyslipidaemia (conditions that cause high levels of fats, including cholesterol, in the blood). It should be used with a low-fat …

Distribution channels: Healthcare & Pharmaceuticals Industry